Ignyte Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IGNYU and buy or sell other stocks, ETFs, and their options commission-free!About IGNYU
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.
CEOStephen J. LaMond, PhD, MBA
CEOStephen J. LaMond, PhD, MBA
Employees—
Employees—
HeadquartersPleasanton, California
HeadquartersPleasanton, California
Founded2016
Founded2016
Employees—
Employees—
IGNYU Key Statistics
Market cap299.70M
Market cap299.70M
Price-Earnings ratio-136.71
Price-Earnings ratio-136.71
Dividend yield—
Dividend yield—
Average volume3.98K
Average volume3.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.00
52 Week high$13.00
52 Week low$9.50
52 Week low$9.50
Stock Snapshot
With a market cap of 299.7M, Ignyte Acquisition Corp. Unit(IGNYU) trades at $12.96. The stock has a price-to-earnings ratio of -136.71.
On 2025-12-13, Ignyte Acquisition Corp. Unit(IGNYU) stock opened at —, reached a high of —, and a low of —.
The Ignyte Acquisition Corp. Unit(IGNYU)'s current trading volume is 0, compared to an average daily volume of 3.98K.
During the past year, Ignyte Acquisition Corp. Unit(IGNYU) stock moved between $9.50 at its lowest and $13.00 at its peak.
During the past year, Ignyte Acquisition Corp. Unit(IGNYU) stock moved between $9.50 at its lowest and $13.00 at its peak.